Bernard Fontana (left) of Framatome and Cosmin Ghiță of Nuclearelectrica. (Photo: Framatome)
Framatome and SN Nuclearelectrica, a partially state-owned Romanian nuclear energy company, have entered into a long-term cooperation agreement to produce the medical isotope lutetium-177 at Cernavoda nuclear power plant in Romania. Lu-177 is a beta-emitting radioisotope used in targeted radionuclide therapy for the treatment of neuroendocrine tumors and prostate cancer.
Framatome’s GAIA Protect EATF assembly. (Photo: Framatome)
Framatome’s enhanced accident tolerant fuel assemblies recently completed a third 18-month fuel cycle at Southern Nuclear’s Vogtle-2 plant—the first of this type of fuel to reach this milestone in the U.S., the company said.
Framatome’s fuel fabrication facility in Richland, Wash. (Photo: Framatome)
TerraPower announced May 29 that it will work with Framatome North America to fund the high-assay low-enriched uranium (HALEU) metallization pilot plant that Framatome is building at its fuel fabrication facility in Richland, Wash. A successful demonstration of Framatome’s capability of converting enriched uranium oxide to HALEU metal will “support the development of the domestic HALEU supply chain,” both companies say.
Framatome’s spray liner rehabilitates buried piping and underground components. (Photo: Framatome)
Framatome was recently awarded a multimillion-dollar contract to perform mitigation of buried condenser feed pipes at a three-unit nuclear power plant in the United States.
The France-based nuclear company plans to install spray-in-place structural pipe liner to mitigate more than one mile of large diameter underground piping connected to plant condenser boxes. The project will be performed during nine outages over eight years, with the first application planned for fall 2025.
Concept art of Framatome's expansion of its Mill Ridge Road facility in Lynchburg, Va. (Image: Framatome)
An official groundbreaking last week at Framatome’s Mill Ridge Road facility, in Lynchburg, Va., marks the start of a $50 million expansion and an eventual addition of 500 employees, according to the nuclear company.
Bulgarian prime minister Dimitar Glavchev, left, and acting energy minister Vladimir Malinov visited Kozloduy nuclear power plant, where Westinghouse is lined up to build two new reactors. (Photo: gov.bg)
Bulgarian officials have approved the transition to Westinghouse fuel at the nation's Kozloduy nuclear power plant, as Bulgaria moves away from its reliance on Russian supplies. The fuel was recently delivered for use in Unit 5.
Catherine Cornand of Framatome and Chang Hee-Seung of KHNP (center) with Framatome and KHNP employees following the signing of the MOU. (Photo: Framatome)
Framatome and Korea Hydro & Nuclear Power (KHNP) have announced the signing of a memorandum of understanding to explore the possibility of producing the medical isotope lutetium-177 at KHNP’s Wolsong nuclear power plant in South Korea. The companies also will investigate the feasibility of using the plant to support Korean production of medical radioisotopes in the future.
A computer-generated rendering of the Sizewell site on the Suffolk coast. Sizewell A and B are to the left and center (respectively) in this image; the section to the right is the Sizewell C area. (Image: EDF Energy)
French nuclear developer Framatome is slated to deliver key equipment for Sizewell C Ltd.’s two large reactors planned for the United Kingdom’s Suffolk coast.
The agreement, reportedly worth multiple billions of euros, was announced this week and will involve Framatome from the design phase until commissioning. The company also agreed to a long-term fuel supply deal. Framatome is 80.5 percent owned by France’s EDF and 19.5 percent owned by Mitsubishi Heavy Industries.
Framatome CEO Bernard Fontana (left) and Teodor Chirica, Nuclearelectrica board president, shake hands following the signing of the Lu-177 MOU in Paris. (Photo: Framatome)
Framatome and Nuclearelectrica, operator of Romania’s Cernavoda nuclear power plant, announced the signing of a memorandum of understanding to explore the possibility of producing the medical isotope lutetium-177. The cooperative agreement was signed during the World Nuclear Exhibition 2023, held November 28–30 in Paris.
Framatome CEO Bernard Fontana (left) shakes hands with Hungarian energy minister Csaba Lantos. (Photo: Framatome)
France-based Framatome and the Hungary’s Ministry of Energy agreed this week to strengthen their relationship in the field of nuclear energy, including in such areas as fuel supply, education, research and development, implementation of new technologies, and long-term operation.
Executives from Westinghouse and Slovenské Elektrárne met in the Slovakian capital of Bratislava to sign the agreement to license and supply VVER-440 fuel assemblies. From left are Aziz Dag, senior vice president and managing director of Westinghouse Electric Sweden; Lukáš Maršálek, deputy director for the accounting, finance, and control department of Slovenské Elektrárne; Tarik Choho, Westinghouse president of nuclear fuel; and Branislav Strýček, director general of Slovenske Elektrárne. (Photo: Westinghouse)
In the latest example of Europe’s move away from its dependence on Russia for VVER reactor fuel, Westinghouse Electric Company on Friday signed a long-term agreement with Slovakia’s nuclear power plant operator, Slovenské Elektrárne, to license and supply VVER-440 fuel assemblies.
From left, Framatome’s CEO Bernard Fontana shakes hands with Slovenské Elektrárne’s CEO Branislav Strýček following the signing of an MOU. Also pictured is first vice chairman of Slovenské Elektrárne’s board of directors, Michele Bologna.
Slovakia’s Slovenské Elektrárne—operator of the nation’s two nuclear power plants, Bohunice and Mochovce—and France’s Framatome have signed a memorandum of understanding for the development of a global strategic relationship, the companies announced last week.
A Framatome operator fabricates U-Mo foils at CERCA. (Photo: Framatome)
Framatome is prepared to manufacture a novel molybdenum-uranium (U-Mo) fuel to extend the life and safe operation of the Forschungsreaktor München II (FRM II) research reactor in Germany. A new fuel supply—one that uses uranium enriched to less than 20 percent U-235—means the FRM II can continue to supply neutrons to industry and the scientific community. The fuel is “Europe’s low-enriched fuel with the highest density ever realized for research reactor operations,” according to Framatome’s April 27 announcement.
Various officials (back row) look on at the fuel supply contract signing in Sofia, Bulgaria. Front row, from left: Angie Darkey, Uranium Asset Management’s managing director; Boris Schucht, Urenco CEO; Tim Gitzel, Cameco president and CEO; and Aziz Dag, Westinghouse senior vice president of global BWR & VVER fuel business.
Canada’s Cameco and U.K.-based Urenco last week jointly announced the signing of agreements to become part of a Westinghouse-led fuel supply chain for Bulgaria’s Kozloduy nuclear power plant. (Also included in the partnership is Uranium Asset Management.)